Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
Petrioli R, Pascucci A, Francini E, Marsili S, Sciandivasci A, Tassi R, Civitelli S, Tanzini G, Lorenzi M, Francini G. Petrioli R, et al. Among authors: francini g, francini e. Cancer Chemother Pharmacol. 2008 Jan;61(1):105-11. doi: 10.1007/s00280-007-0454-3. Epub 2007 Apr 12. Cancer Chemother Pharmacol. 2008. PMID: 17429632 Clinical Trial.
Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.
Petrioli R, Pascucci A, Francini E, Marsili S, Fiaschi AI, Civitelli S, Tanzini G, Battistelli S, Lorenzi M, Roviello F, Francini G; Multidisciplinary Oncology Group on Gastrointestinal Tumors. Petrioli R, et al. Among authors: francini g, francini e. Anticancer Drugs. 2008 Jan;19(1):91-6. doi: 10.1097/CAD.0b013e3282f21363. Anticancer Drugs. 2008. PMID: 18043134
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.
Petrioli R, Bargagli G, Lazzi S, Pascucci A, Francini E, Bellan C, Conca R, Martellucci I, Fiaschi AI, Lorenzi B, Francini G; Multidisciplinary Oncology Group in Gastrointestinal Tumors. Petrioli R, et al. Among authors: francini g, francini e. Anticancer Drugs. 2010 Mar;21(3):313-9. doi: 10.1097/CAD.0b013e328334d88a. Anticancer Drugs. 2010. PMID: 20016369 Clinical Trial.
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer.
Petrioli R, Francini E, Cherri S, Torre P, Fiaschi AI, Miano ST, Marrelli D, Rovello F, Francini G. Petrioli R, et al. Among authors: francini g, francini e. Clin Colorectal Cancer. 2018 Dec;17(4):e663-e669. doi: 10.1016/j.clcc.2018.07.002. Epub 2018 Jul 4. Clin Colorectal Cancer. 2018. PMID: 30153975
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer.
Petrioli R, Francini E, Cherri S, Marrelli D, Rovello F, Fiaschi AI, Miano ST, Savelli V, Calomino N, Farsi M, Vernillo R, Francini G. Petrioli R, et al. Among authors: francini g. Anticancer Drugs. 2020 Mar;31(3):292-297. doi: 10.1097/CAD.0000000000000877. Anticancer Drugs. 2020. PMID: 31850915
142 results